Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adobe Systems Inc (ADBE) vs Cassava Sciences Inc (FLNA) Price & Performance

Adobe Systems IncTrade
Cassava Sciences IncTrade

Price performance (Past 24H)

Key statistics

Adobe Systems Inc vs Cassava Sciences Inc — how do they compare? Adobe Systems Inc trades at $260.63 (market cap $104.82B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Adobe Systems Inc is far larger — about 2195.2× Cassava Sciences Inc's market cap, and Adobe Systems Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.

ADBEFLNA
Market Cap
$104.82B$47.75M
Volume
5,187,646
Sector
TechnologyHealth
52-Week High
$367.46$4.64
52-Week Low
$193.41$0.87
Enterprise Value
$106.26B-$34.93M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Adobe Systems Inc

Adobe (ADBE) trades at $272.96, up 2.92% with strong technical momentum above key support at $270. The company demonstrates robust fundamentals with 2025 revenue of $23.77B and net income of $7.13B, maintaining exceptional profitability with 89.4% gross margins. Recent earnings beats and accelerating revenue growth contrast with mixed sentiment amid AI competition concerns and CEO transition uncertainty.

ADBE presents a compelling value proposition trading below analyst consensus targets with strong cash flow generation, though faces headwinds from AI disruption fears and sector volatility. The stock's current valuation at 15.62 P/E offers potential upside if execution continues, but requires monitoring of competitive threats and leadership stability.

Cassava Sciences Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About Adobe Systems Inc

Adobe Inc. develops, markets, and supports computer software products and technologies. The Company's products allow users to express and use information across all print and electronic media. Adobe offers a line of application software products, type products, and content for creating, distributing, and managing information.

Read more on ADBE

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA